Skip to main content

Table 3 The 10-year disease-free survival rates and univariate Cox regression analysis

From: The reversal of recurrence hazard rate between ER positive and negative breast cancer patients with axillary lymph node dissection (pathological stage I-III) 3 years after surgery

Factors disease-free survival rates Hazard ratio   Log-rank test
p-value
  10-year (%) 95% CI a   95% CI a  
Age      
   < 35 47.0 33.3–60.7 1.00 - 0.49
   35–54 59.0 55.7–62.4 0.91 0.50–1.64  
   ≥ 55 63.1 59.4–66.7 0.90 0.50–1.63  
cTNM      
   Stage I 72.4 67.3–77.6 1.00 - <0.001
   Stage II 60.9 58.0–63.9 2.05 1.45–2.91  
   Stage III 31.5 24.8–38.2 5.03 3.36–7.52  
pTNM      
   Stage I 81.7 77.4–85.9 1.00 - <0.001
   Stage II 67.5 64.4–70.5 2.18 1.47–3.24  
   Stage III 17.7 13.1–22.4 7.66 5.13–11.43  
pN      
   pN0 76.6 73.8–79.5 1.00 - <0.001
   pN1 56.4 51.6–61.2 1.85 1.36–2.53  
   pN2 15.5 10.3–20.7 5.75 4.22–7.83  
   pN3 26.8 16.6–37.1 4.88 3.25–7.32  
ER status      
   Negative 59.8 56.4–63.2 1.00 - 0.183
   Positive 60.0 56.6–63.4 0.83 0.63–1.09  
Breast surgery      
   Breast conserving surgery 59.1 54.1–64.0 1.00 - 0.007
   Modified radical mastectomy 61.5 58.7–64.3 1.14 0.86–1.52  
   Standard radical mastectomy NDb - 3.34 1.76–6.33  
  1. a CI: Confidence interval,b ND: not determined.